US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
US4874237A
(en)
|
1987-05-07 |
1989-10-17 |
Lions Eye Inst. Of Western Australia |
Electroretinogram apparatus
|
EP0441897A4
(en)
|
1988-11-14 |
1992-06-24 |
Us Health |
Parvovirus capsids
|
FR2643252B1
(fr)
|
1989-02-21 |
1991-06-07 |
Technomed Int Sa |
Appareil de destruction selective de cellules incluant les tissus mous et les os a l'interieur du corps d'un etre vivant par implosion de bulles de gaz
|
US5112946A
(en)
|
1989-07-06 |
1992-05-12 |
Repligen Corporation |
Modified pf4 compositions and methods of use
|
US5436146A
(en)
|
1989-09-07 |
1995-07-25 |
The Trustees Of Princeton University |
Helper-free stocks of recombinant adeno-associated virus vectors
|
US6287815B1
(en)
|
1989-09-14 |
2001-09-11 |
Rijksuniversiteit Te Leiden |
Human parvovirus B19 proteins and virus-like particles, their production and their use in diagnostic assays and vaccines
|
EP0557459B1
(de)
|
1990-11-13 |
1997-10-22 |
Immunex Corporation |
Bifunktionelle wählbare fusionsgene
|
US5383917A
(en)
|
1991-07-05 |
1995-01-24 |
Jawahar M. Desai |
Device and method for multi-phase radio-frequency ablation
|
GB9206016D0
(en)
|
1992-03-19 |
1992-04-29 |
Sandoz Ltd |
Improvements in or relating to organic compounds
|
EP0694042B1
(de)
|
1993-03-25 |
2004-11-03 |
Merck & Co. Inc. |
Inhibitor des wachstumsfaktors für gefäss-endothelzellen
|
EP0804590A1
(de)
|
1993-05-21 |
1997-11-05 |
Targeted Genetics Corporation |
Bifunktionelle selektierbare fusionsgene auf dem cytosin-deaminase (cd) gen beruhend
|
US5814618A
(en)
|
1993-06-14 |
1998-09-29 |
Basf Aktiengesellschaft |
Methods for regulating gene expression
|
EP0745134A1
(de)
|
1994-02-22 |
1996-12-04 |
Danafarber Cancer Institute |
Nukleinsäureverabreichungs-system, verfahren zur dessen synthese und seine verwendungen
|
US6551618B2
(en)
|
1994-03-15 |
2003-04-22 |
University Of Birmingham |
Compositions and methods for delivery of agents for neuronal regeneration and survival
|
FR2718150B1
(fr)
|
1994-03-29 |
1996-04-26 |
Rhone Poulenc Rorer Sa |
Virus recombinants, préparation et utilisation en thérapie génique.
|
US5639725A
(en)
|
1994-04-26 |
1997-06-17 |
Children's Hospital Medical Center Corp. |
Angiostatin protein
|
US5527533A
(en)
|
1994-10-27 |
1996-06-18 |
Board Of Trustees Of The University Of Illinois |
Method of retarding and ameliorating central nervous system and eye damage
|
US20020168342A1
(en)
|
1994-11-03 |
2002-11-14 |
Cell Genesys, Inc. |
Novel adenoviral vectors, packaging cell lines, recombinant adenoviruses and methods
|
US6440425B1
(en)
|
1995-05-01 |
2002-08-27 |
Aventis Pasteur Limited |
High molecular weight major outer membrane protein of moraxella
|
US6040183A
(en)
|
1995-06-07 |
2000-03-21 |
University Of North Carloina At Chapel Hill |
Helper virus-free AAV production
|
US6093570A
(en)
|
1995-06-07 |
2000-07-25 |
The University Of North Carolina At Chapel Hill |
Helper virus-free AAV production
|
US6001650A
(en)
|
1995-08-03 |
1999-12-14 |
Avigen, Inc. |
High-efficiency wild-type-free AAV helper functions
|
US6013516A
(en)
|
1995-10-06 |
2000-01-11 |
The Salk Institute For Biological Studies |
Vector and method of use for nucleic acid delivery to non-dividing cells
|
US5641749A
(en)
|
1995-11-29 |
1997-06-24 |
Amgen Inc. |
Method for treating retinal ganglion cell injury using glial cell line-derived neurothrophic factor (GDNF) protein product
|
US6096548A
(en)
|
1996-03-25 |
2000-08-01 |
Maxygen, Inc. |
Method for directing evolution of a virus
|
WO1997038723A1
(en)
|
1996-04-16 |
1997-10-23 |
Immusol Incorporated |
Targeted viral vectors
|
KR100405285B1
(ko)
|
1996-08-20 |
2003-11-12 |
더 리전트 오브 더 유니버시티 오브 캘리포니아 |
합성 티로이드 호르몬을 포함하는 약제 조성물
|
WO1998013071A1
(en)
|
1996-09-24 |
1998-04-02 |
Merck & Co., Inc. |
Gene therapy for inhibition of angiogenesis
|
FR2756297B1
(fr)
|
1996-11-22 |
1999-01-08 |
Centre Nat Rech Scient |
Procede de production de virus recombinants
|
US6153436A
(en)
*
|
1997-01-10 |
2000-11-28 |
The Board Of Trustees Of The University Of Arkansas |
Method of gene delivery using wildtype adeno associated viral (AAV) vectors with insertions
|
ATE270324T1
(de)
|
1997-04-14 |
2004-07-15 |
Cell Genesys Inc |
Methoden zur erhöhung der effizienz rekombinanter aav produkte
|
WO1998051323A1
(en)
|
1997-05-13 |
1998-11-19 |
The Regents Of The University Of California |
Novel antiangiogenic peptide agents and their therapeutic and diagnostic use
|
US6710036B2
(en)
|
1997-07-25 |
2004-03-23 |
Avigen, Inc. |
Induction of immune response to antigens expressed by recombinant adeno-associated virus
|
US6458157B1
(en)
|
1997-08-04 |
2002-10-01 |
Suaning Gregg Joergen |
Retinal stimulator
|
AU9319198A
(en)
|
1997-09-19 |
1999-04-05 |
Trustees Of The University Of Pennsylvania, The |
Methods and vector constructs useful for production of recombinant aav
|
JPH11100327A
(ja)
|
1997-09-26 |
1999-04-13 |
Toray Ind Inc |
網膜変性症治療剤
|
AU9673998A
(en)
|
1997-10-01 |
1999-04-23 |
G.D. Searle & Co. |
Fusion proteins comprising an angiostatin moiety and their use in anti-tumor treatment
|
EP1030861A4
(de)
|
1997-10-31 |
2001-09-05 |
Maxygen Inc |
Modifizierung des virustropismius und des wirtspektrums durch virale genomdurchmischung
|
US5994136A
(en)
|
1997-12-12 |
1999-11-30 |
Cell Genesys, Inc. |
Method and means for producing high titer, safe, recombinant lentivirus vectors
|
US6410300B1
(en)
|
1998-01-12 |
2002-06-25 |
The University Of North Carolina At Chapel Hill |
Methods and formulations for mediating adeno-associated virus (AAV) attachment and infection and methods for purifying AAV
|
WO1999036511A2
(en)
|
1998-01-16 |
1999-07-22 |
Chiron Corporation |
Feline immunodeficiency virus gene therapy vectors
|
US6551795B1
(en)
|
1998-02-18 |
2003-04-22 |
Genome Therapeutics Corporation |
Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics
|
DE69903612T2
(de)
|
1998-03-12 |
2003-07-10 |
Genentech Inc |
Verwendung von fgf-5 polypetiden zur vorbeugung des absterbens retinaler neuronen und behandlung okularer krankheiten
|
DE19827457C1
(de)
|
1998-06-19 |
2000-03-02 |
Medigene Ag |
Strukturprotein von AAV, seine Herstellung und Verwendung
|
US6593133B1
(en)
|
1998-07-06 |
2003-07-15 |
Nsgene A/S |
Neurotrophic factors
|
WO2000012740A2
(en)
|
1998-08-28 |
2000-03-09 |
Duke University |
ADENOVIRUSES DELETED IN THE IVa2, 100K AND/OR PRETERMINAL PROTEIN SEQUENCES
|
CA2342283C
(en)
|
1998-09-11 |
2004-05-25 |
The Regents Of The University Of California |
Recombinant adenovirus for tissue specific expression in heart
|
NZ511037A
(en)
|
1998-09-17 |
2005-02-25 |
Univ Florida |
Methods for treatment of degenerative retinal diseases
|
US20040234505A1
(en)
|
1998-09-23 |
2004-11-25 |
Stuart Naylor |
Polynucleotide constructs and uses thereof
|
EP1135468B1
(de)
|
1998-11-10 |
2010-01-06 |
University Of North Carolina At Chapel Hill |
Virusvektoren und verfahren für ihre herstellung und verabreichung.
|
US6943153B1
(en)
|
1999-03-15 |
2005-09-13 |
The Regents Of The University Of California |
Use of recombinant gene delivery vectors for treating or preventing diseases of the eye
|
CA2367375A1
(en)
|
1999-03-15 |
2000-09-21 |
Chiron Corporation |
Use of recombinant gene delivery vectors for treating or preventing diseases of the eye
|
US6498244B1
(en)
|
1999-05-28 |
2002-12-24 |
Cell Genesys, Inc. |
Adeno-associated virus capsid immunologic determinants
|
US7306799B2
(en)
|
1999-06-08 |
2007-12-11 |
Regeneron Pharmaceuticals, Inc. |
Use of VEGF inhibitors for treatment of eye disorders
|
US7070959B1
(en)
|
1999-06-08 |
2006-07-04 |
Regeneron Pharmaceuticals, Inc. |
Modified chimeric polypeptides with improved pharmacokinetic properties
|
US7087411B2
(en)
|
1999-06-08 |
2006-08-08 |
Regeneron Pharmaceuticals, Inc. |
Fusion protein capable of binding VEGF
|
US7314912B1
(en)
|
1999-06-21 |
2008-01-01 |
Medigene Aktiengesellschaft |
AAv scleroprotein, production and use thereof
|
DE19933288A1
(de)
|
1999-07-15 |
2001-01-18 |
Medigene Ag |
Strukturprotein von Adeno-assoziiertem Virus mit veränderter Antigenität, seine Herstellung und Verwendung
|
DE19933719A1
(de)
|
1999-07-19 |
2001-01-25 |
Medigene Ag |
Strukturprotein in Adeno-assoziiertem Virus mit veränderten chromatographischen Eigenschaften, seine Herstellung und Verwendung
|
US8232081B2
(en)
|
1999-09-21 |
2012-07-31 |
Basf Se |
Methods and microorganisms for production of panto-compounds
|
WO2001034018A2
(en)
|
1999-10-25 |
2001-05-17 |
Therus Corporation |
Use of focused ultrasound for vascular sealing
|
US6855314B1
(en)
|
2000-03-22 |
2005-02-15 |
The United States Of America As Represented By The Department Of Health And Human Services |
AAV5 vector for transducing brain cells and lung cells
|
NZ521952A
(en)
|
2000-04-17 |
2004-03-26 |
Stuart Graham |
Method and apparatus for electrophysiological assessment of visual function using a head-mounted stereo display
|
US6329181B1
(en)
|
2000-08-07 |
2001-12-11 |
Neurologix, Inc. |
Helper functions for recombinant vector production
|
WO2002053703A2
(en)
|
2001-01-05 |
2002-07-11 |
Children's Hospital, Inc. |
Aav2 vectors and methods
|
US7749492B2
(en)
|
2001-01-05 |
2010-07-06 |
Nationwide Children's Hospital, Inc. |
AAV vectors and methods
|
ES2386718T3
(es)
|
2001-02-06 |
2012-08-28 |
Qlt Inc. |
Terapía fotodinámica para la degeneración macular asociada a la edad oculta
|
EP1372552B1
(de)
|
2001-03-27 |
2017-03-01 |
WaveLight GmbH |
Vorrichtung zur bearbeitung und diagnose von augengewebe
|
EP1386004A4
(de)
|
2001-04-05 |
2005-02-16 |
Ribozyme Pharm Inc |
Modulation der mit der entzündungsausbreitung und dem neuritenauswuchs assoziierten genexpression unter verwendung von technologien auf nukleinsäurebasis
|
EP1381276A4
(de)
|
2001-04-13 |
2005-02-02 |
Univ Pennsylvania |
Verfahren zur behandlung oder zur entwicklungsverlangsamung von blindheit
|
JP2002363107A
(ja)
|
2001-06-04 |
2002-12-18 |
Noriyuki Azuma |
色覚不全動物の色覚復元方法
|
WO2003012054A2
(en)
|
2001-08-02 |
2003-02-13 |
Institut Clayton De La Recherche |
Methods and compositions relating to improved lentiviral vector production systems
|
US20030129203A1
(en)
|
2001-08-27 |
2003-07-10 |
Nautilus Biotech S.A. |
Mutant recombinant adeno-associated viruses
|
US7647184B2
(en)
|
2001-08-27 |
2010-01-12 |
Hanall Pharmaceuticals, Co. Ltd |
High throughput directed evolution by rational mutagenesis
|
US6723551B2
(en)
|
2001-11-09 |
2004-04-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Production of adeno-associated virus in insect cells
|
ATE317916T1
(de)
|
2001-11-13 |
2006-03-15 |
Univ Pennsylvania |
Verfahren zur identifizierung von adeno- assoziiertem virus (aav) sequenzen sowie kit zur ausführung der methode
|
WO2003054197A2
(de)
|
2001-12-21 |
2003-07-03 |
Medigene Ag |
A librairy of modified structural genes or capsid modified particles useful for the identification of viral clones with desired cell tropism
|
EP1490113A4
(de)
|
2002-03-20 |
2007-05-02 |
Univ Florida |
Raav-vektor-zusammensetzungen und verfahren zur behandlung von choroidaler neovaskularisation
|
AU2003221733A1
(en)
|
2002-04-17 |
2003-11-03 |
University Of Florida Research Foundation, Inc. |
Improved raav vectors
|
WO2003093436A2
(en)
|
2002-04-30 |
2003-11-13 |
University Of Florida |
Treatment for phenylketonuria
|
US7858367B2
(en)
|
2002-04-30 |
2010-12-28 |
Duke University |
Viral vectors and methods for producing and using the same
|
US7254489B2
(en)
|
2002-05-31 |
2007-08-07 |
Microsoft Corporation |
Systems, methods and apparatus for reconstructing phylogentic trees
|
US8304233B2
(en)
|
2002-06-04 |
2012-11-06 |
Poetic Genetics, Llc |
Methods of unidirectional, site-specific integration into a genome, compositions and kits for practicing the same
|
AU2003265855A1
(en)
|
2002-08-28 |
2004-03-19 |
University Of Florida |
Modified aav
|
GB0220467D0
(en)
|
2002-09-03 |
2002-10-09 |
Oxford Biomedica Ltd |
Composition
|
JP2006519026A
(ja)
|
2003-03-04 |
2006-08-24 |
独立行政法人産業技術総合研究所 |
標的物質の細胞導入効率を上昇させるための組成物および方法
|
WO2004083441A2
(en)
|
2003-03-19 |
2004-09-30 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Random peptide library displayed on aav vectors
|
WO2004108922A2
(en)
|
2003-04-25 |
2004-12-16 |
The Trustees Of The University Of Pennsylvania |
Use of aav comprising a capsid protein from aav7 or aav8 for the delivery of genes encoding apoprotein a or e genes to the liver
|
EP1486567A1
(de)
|
2003-06-11 |
2004-12-15 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Verbesserter Adeno-assoziierter Virus (AAV)-Vektor für Gentherapie
|
HUE034546T2
(en)
|
2003-06-19 |
2018-02-28 |
Genzyme Corp |
Reduced immunoreactivity of AAV virions and their applications
|
US7368428B2
(en)
|
2003-06-23 |
2008-05-06 |
A&G Pharmaceutical, Inc. |
Compositions and methods for restoring sensitivity of tumor cells to antitumor therapy and inducing apoptosis
|
US9233131B2
(en)
|
2003-06-30 |
2016-01-12 |
The Regents Of The University Of California |
Mutant adeno-associated virus virions and methods of use thereof
|
US9441244B2
(en)
|
2003-06-30 |
2016-09-13 |
The Regents Of The University Of California |
Mutant adeno-associated virus virions and methods of use thereof
|
EP1670897A4
(de)
|
2003-09-24 |
2008-02-27 |
Univ Leland Stanford Junior |
Igf-1 weist multipotente adulte neurale zns-stammzellen in eine oligodendrogliazellinie
|
US7906111B2
(en)
|
2003-09-30 |
2011-03-15 |
The Trustees Of The University Of Pennsylvania |
Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor
|
US20060166363A1
(en)
|
2004-01-27 |
2006-07-27 |
Sergei Zolotukhin |
Modified baculovirus expression system for production of pseudotyped rAAV vector
|
US7427396B2
(en)
|
2004-06-03 |
2008-09-23 |
Genzyme Corporation |
AAV vectors for gene delivery to the lung
|
RS52539B
(en)
|
2004-10-21 |
2013-04-30 |
Genentech Inc. |
METHOD FOR TREATMENT OF INTRAOCULAR NEOVASCULAR DISEASES
|
NZ553700A
(en)
*
|
2004-11-08 |
2010-09-30 |
Chromagenics Bv |
Selection of host cells expressing protein at high levels using a selectable marker with a non-optimal start codon
|
EP1828390B1
(de)
|
2004-12-15 |
2012-06-13 |
The University Of North Carolina At Chapel Hill |
Chimäre vektoren
|
WO2006101634A1
(en)
|
2005-02-17 |
2006-09-28 |
The Regents Of The University Of California |
Müller cell specific gene therapy
|
US7922670B2
(en)
|
2005-02-24 |
2011-04-12 |
Warren Jones |
System and method for quantifying and mapping visual salience
|
EP1866422B1
(de)
|
2005-04-07 |
2016-04-06 |
The Trustees of The University of Pennsylvania |
Methode um die funktion eines aav vektors zu erhöhen
|
US20060234347A1
(en)
|
2005-04-13 |
2006-10-19 |
Harding Thomas C |
Targeting multiple angiogenic pathways for cancer therapy using soluble tyrosine kinase receptors
|
CA2622233C
(en)
|
2005-10-20 |
2015-01-20 |
Amsterdam Molecular Therapeutics (Amt) B.V. |
Improved aav vectors produced in insect cells
|
EP1981548A4
(de)
|
2006-01-20 |
2010-03-24 |
Univ North Carolina |
Verstärkte produktion von infektiösen parvovirus-vektoren in insektenzellen
|
WO2007089632A2
(en)
|
2006-01-27 |
2007-08-09 |
The University Of North Carolina At Chapel Hill |
Heparin and heparan sulfate binding chimeric vectors
|
US20070190028A1
(en)
|
2006-02-13 |
2007-08-16 |
Jihong Qu |
Method and apparatus for heat or electromagnetic control of gene expression
|
US8118752B2
(en)
|
2006-02-16 |
2012-02-21 |
The Board Of Trustees Of The University Of Illinois |
Apparatus and methods for mapping retinal function
|
US7384145B2
(en)
|
2006-02-16 |
2008-06-10 |
The Board Of Trustees Of The University Of Illinois |
Mapping retinal function using corneal electrode array
|
EP2007795B1
(de)
|
2006-03-30 |
2016-11-16 |
The Board Of Trustees Of The Leland Stanford Junior University |
Aav-capsid-proteine
|
US8216575B2
(en)
|
2006-03-31 |
2012-07-10 |
Chengdu Kanghong Biotechnologies Co., Ltd. |
Inhibition of neovascularization with a soluble chimeric protein comprising VEGF FLT-1 and KDR domains
|
US8470790B2
(en)
|
2006-05-04 |
2013-06-25 |
Wayne State University |
Restoration of visual responses by in vivo delivery of rhodopsin nucleic acids
|
JP2009535371A
(ja)
|
2006-05-04 |
2009-10-01 |
フォベア、ファルマスティカル、ソシエテ、アノニム |
血管新生性疾患の治療のための方法
|
ES2390499T3
(es)
|
2006-06-12 |
2012-11-13 |
Opko Pharmaceuticals, Llc |
Composiciones y métodos para la inhibición de la angiogénesis por sirna
|
GB0612096D0
(en)
|
2006-06-19 |
2006-07-26 |
Greater Glasgow Nhs Board |
Functional imaging of the retina
|
US8512981B2
(en)
|
2006-06-21 |
2013-08-20 |
Amsterdam Molecular Therapeutics B.V. |
Vectors with modified initiation codon for the translation of AAV-Rep78 useful for production of AAV
|
JPWO2008001543A1
(ja)
|
2006-06-27 |
2009-11-26 |
株式会社アドバンテスト |
半導体試験装置および半導体メモリの試験方法
|
ES2385679T3
(es)
|
2006-08-24 |
2012-07-30 |
Virovek, Inc. |
Expresión de células de insecto de genes con marcos de lectura abiertos superpuestos, métodos y composiciones de éstos
|
CN1966082B
(zh)
|
2006-11-03 |
2010-06-30 |
许瑞安 |
一种防治结直肠癌的基因药物及其制备方法和用途
|
WO2008098310A1
(en)
|
2007-02-16 |
2008-08-21 |
Objectivision Limited |
Stimulus method for multifocal visual evoked potential
|
US9725485B2
(en)
|
2012-05-15 |
2017-08-08 |
University Of Florida Research Foundation, Inc. |
AAV vectors with high transduction efficiency and uses thereof for gene therapy
|
NZ593611A
(en)
|
2007-04-13 |
2012-06-29 |
Catalyst Biosciences Inc |
Modified factor vii polypeptides and uses thereof
|
EP1985708B1
(de)
|
2007-04-27 |
2015-04-15 |
Universität Rostock |
Selektives Targeting von Viren in neurale Vorläuferzellen
|
EP1995309A1
(de)
|
2007-05-21 |
2008-11-26 |
Vivalis |
Rekombinante Proteinproduktion in EBx -Vogelzellen
|
US10696983B2
(en)
|
2007-05-30 |
2020-06-30 |
The Trustees Of The University Of Pennsylvania |
Method for transducing cells with primary cilia
|
US8540369B2
(en)
|
2007-08-16 |
2013-09-24 |
The Research Foundation Of State University Of New York |
Led variable light source
|
US8518037B2
(en)
|
2007-10-30 |
2013-08-27 |
Boston Scientific Scimed, Inc. |
Radiofrequency ablation device
|
JP2011505147A
(ja)
|
2007-11-30 |
2011-02-24 |
スカラブ ゲノミクス, エルエルシー |
lac発現システム
|
EA020969B1
(ru)
|
2008-02-19 |
2015-03-31 |
ЮНИКЬЮРЕ АйПи Б.В. |
ОПТИМИЗАЦИЯ ЭКСПРЕССИИ ПАРВОВИРУСНЫХ БЕЛКОВ Rep И Cap В КЛЕТКАХ НАСЕКОМЫХ
|
CN101951925A
(zh)
|
2008-02-20 |
2011-01-19 |
建新公司 |
血管发生抑制
|
WO2009105690A2
(en)
|
2008-02-21 |
2009-08-27 |
Targeted Genetics Corporation |
Devices and methods for delivering polynucleotides into retinal cells of the macula and fovea
|
ITFI20080081A1
(it)
|
2008-04-18 |
2009-10-19 |
Strumenti Oftalmici C S O S R |
Procedimento e sistema per la registrazione di risposte elettrofunzionali erg, perg e vep multifocali in tempo reale
|
WO2009137006A2
(en)
|
2008-04-30 |
2009-11-12 |
The University Of North Carolina At Chapel Hill |
Directed evolution and in vivo panning of virus vectors
|
WO2010011404A2
(en)
|
2008-05-20 |
2010-01-28 |
Eos Neuroscience, Inc. |
Vectors for delivery of light-sensitive proteins and methods of use
|
ES2330826B1
(es)
|
2008-06-04 |
2010-07-26 |
Proyecto De Biomedicina Cima, S.L. |
Sistema para empaquetamiento de adenovirus de alta capacidad.
|
US20110171262A1
(en)
|
2008-06-17 |
2011-07-14 |
Andrew Christian Bakker |
Parvoviral capsid with incorporated gly-ala repeat region
|
US9192685B2
(en)
|
2008-10-07 |
2015-11-24 |
Bracco Suisse S.A. |
Targeting construct comprising anti-polymer antibody and contrast/therapeutic agents binding to the same
|
EP2396343B1
(de)
|
2009-02-11 |
2017-05-17 |
The University of North Carolina At Chapel Hill |
Modifizierte virusvektoren sowie verfahren zu ihrer herstellung und verwendung
|
EP2403867B1
(de)
|
2009-03-04 |
2019-05-22 |
Deutsches Krebsforschungszentrum |
Assembly activating protein (aap) und dessen verwendung zur herstellung von parvoviruspartikeln, die im wesentlichen aus vp3 bestehen
|
US8679837B2
(en)
|
2009-04-02 |
2014-03-25 |
University Of Florida Research Foundation, Inc. |
Inducible system for highly efficient production of recombinant Adeno-associated virus (rAAV) vectors
|
CN101532024A
(zh)
|
2009-04-30 |
2009-09-16 |
许瑞安 |
一种用于基因治疗的新型细胞特异性内含microRNA结合序列的基因HAAVmir
|
US8734809B2
(en)
|
2009-05-28 |
2014-05-27 |
University Of Massachusetts |
AAV's and uses thereof
|
TWI466158B
(zh)
|
2009-07-03 |
2014-12-21 |
Univ Lunghwa Sci & Technology |
電漿測量裝置、電漿系統及測量電漿特性之方法
|
EP2287323A1
(de)
|
2009-07-31 |
2011-02-23 |
Association Institut de Myologie |
Weitverbreitete Genverabreichung an die Netzhaut mithilfe der systemischen Verabreichung von AAV-Vektoren
|
EP2292781A1
(de)
|
2009-08-17 |
2011-03-09 |
Genethon |
Baculovirus-basierte Herstellung von Biopharmazeutika ohne kontaminierende baculovirale Virionen
|
US20120172419A1
(en)
|
2009-09-15 |
2012-07-05 |
Medical College Of Wisconsin Research Foundation Inc. |
Reagents and methods for modulating cone photoreceptor activity
|
ES2683695T3
(es)
|
2010-01-12 |
2018-09-27 |
The University Of North Carolina At Chapel Hill |
Repeticiones terminales invertidas restrictivas para vectores virales
|
EP2545165B1
(de)
|
2010-03-11 |
2020-07-29 |
uniQure IP B.V. |
Mutierte rep-kodierende sequenzen zur verwendung in der aav-produktion
|
WO2011117258A2
(en)
|
2010-03-22 |
2011-09-29 |
Association Institut De Myologie |
Methods of increasing efficiency of vector penetration of target tissue
|
SG183929A1
(en)
|
2010-03-29 |
2012-10-30 |
Univ Pennsylvania |
Pharmacologically induced transgene ablation system
|
WO2011122950A1
(en)
|
2010-04-01 |
2011-10-06 |
Amsterdam Molecular Therapeutics (Amt) Ip B.V. |
Monomeric duplex aav vectors
|
CN201704771U
(zh)
|
2010-04-30 |
2011-01-12 |
陈福环 |
无水箱节水型抽水马桶
|
US9102718B2
(en)
|
2010-04-30 |
2015-08-11 |
Lpath, Inc. |
Anti-S1P antibody treatment of patients with ocular disease
|
WO2011140450A1
(en)
|
2010-05-07 |
2011-11-10 |
Medicinelodge, Inc Dba Imds Co-Innovation |
Surgical rasp with radiofrequency ablation
|
US8663624B2
(en)
|
2010-10-06 |
2014-03-04 |
The Regents Of The University Of California |
Adeno-associated virus virions with variant capsid and methods of use thereof
|
US20110052678A1
(en)
|
2010-11-05 |
2011-03-03 |
Shantha Totada R |
Method for treating age related macular degeneration
|
JP6092782B2
(ja)
|
2010-11-16 |
2017-03-08 |
エクセリミューン, インコーポレイテッド |
組換えタンパク質の製造方法
|
EP2661494B1
(de)
*
|
2011-01-07 |
2019-06-12 |
Applied Genetic Technologies Corporation |
Promotoren, expressionskassetten und vektoren zur behandlung von farbenblindheit und anderen störungen
|
LT3254703T
(lt)
|
2011-04-22 |
2020-05-25 |
The Regents Of The University Of California |
Adenoasocijuoto viruso virionai su variantine kapside ir jų panaudojimo būdai
|
EP3147295B2
(de)
|
2011-08-24 |
2023-11-22 |
The Board of Trustees of the Leland Stanford Junior University |
Neue aav-capsid-proteine zum transport von nukleinsäuren
|
WO2013063601A1
(en)
|
2011-10-28 |
2013-05-02 |
University Of Florida Research Foundation, Inc. |
Chimeric promoter for cone photoreceptor targeted gene therapy
|
US9677088B2
(en)
|
2012-05-09 |
2017-06-13 |
Oregon Health & Science University |
Adeno associated virus plasmids and vectors
|
TWI698240B
(zh)
|
2012-05-15 |
2020-07-11 |
澳大利亞商艾佛蘭屈澳洲私營有限公司 |
使用腺相關病毒(aav)sflt-1治療老年性黃斑部退化(amd)
|
US20150111275A1
(en)
|
2012-06-11 |
2015-04-23 |
Daniel V. Palanker |
Optical regulation of gene expression in the retina
|
CN104937100B
(zh)
|
2012-12-25 |
2020-04-03 |
宝生物工程株式会社 |
Aav 变体
|
EP2996725A4
(de)
|
2013-05-16 |
2016-12-28 |
Applied Genetic Tech Corp |
Promotoren, expressionskassetten, vektoren, kits und verfahren zur behandlung von farbenblindheit und anderen störungen
|
CA2913869C
(en)
|
2013-05-29 |
2023-01-24 |
Cellectis |
New compact scaffold of cas9 in the type ii crispr system
|
CN105247044B
(zh)
|
2013-05-31 |
2021-05-07 |
加利福尼亚大学董事会 |
腺相关病毒变体及其使用方法
|
WO2014207190A1
(en)
|
2013-06-28 |
2014-12-31 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for expressing a polynucleotide of interest in the retina of a subject
|
US20150025939A1
(en)
|
2013-07-18 |
2015-01-22 |
Somnath Chatterjee |
Company Centric Social Media Platfonn for Content Sharing aud Tracking
|
EP3561062A1
(de)
|
2013-09-13 |
2019-10-30 |
California Institute of Technology |
Selektive rückgewinnung
|
EP3633041A3
(de)
|
2013-09-26 |
2020-07-29 |
University of Florida Research Foundation, Inc. |
Kombinatorische synthetische aav-capsid-bibliothek für zielgerichtete gentherapie
|
EP3060575B1
(de)
|
2013-10-11 |
2018-12-05 |
Massachusetts Eye & Ear Infirmary |
Verfahren zur vorhersage anzestraler virussequenzen und verwendungen davon
|
JP6607850B2
(ja)
|
2013-10-18 |
2019-11-20 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
Vegfアンタゴニスト及び抗ctla−4抗体の組み合わせを含む方法及び組成物
|
EP3113787B1
(de)
|
2014-03-04 |
2019-12-04 |
University of Florida Research Foundation, Inc. |
Verbesserte raav-vektoren und verfahren zur transduktion von fotorezeptoren und rpe-zellen
|
US10000741B2
(en)
|
2014-03-17 |
2018-06-19 |
Adverum Biotechnologies, Inc. |
Compositions and methods for enhanced gene expression in cone cells
|
LT3137497T
(lt)
|
2014-05-02 |
2021-07-26 |
Genzyme Corporation |
Aav vektoriai, skirti tinklainės ir cns genų terapijai
|
CA2951707A1
(en)
|
2014-06-10 |
2015-12-17 |
Massachusetts Institute Of Technology |
Method for gene editing
|
WO2016141078A1
(en)
|
2015-03-02 |
2016-09-09 |
Avalanche Biotechnologies, Inc. |
Compositions and methods for intravitreal delivery of polynucleotides to retinal cones
|
RS60668B1
(sr)
|
2015-03-06 |
2020-09-30 |
Massachusetts Eye & Ear Infirmary |
Terapije augmentacije gena za naslednu degeneraciju retine uzrokovanu mutacijama u genu prpf31
|
WO2017023724A1
(en)
|
2015-07-31 |
2017-02-09 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of aadc deficiency
|
GB2545763A
(en)
|
2015-12-23 |
2017-06-28 |
Adverum Biotechnologies Inc |
Mutant viral capsid libraries and related systems and methods
|
WO2017190125A1
(en)
|
2016-04-29 |
2017-11-02 |
Adverum Biotechnologies, Inc. |
Evasion of neutralizing antibodies by a recombinant adeno-associated virus
|
CA3022667A1
(en)
|
2016-05-03 |
2017-11-09 |
Adverum Biotechnologies, Inc. |
Organotypic pig retina culture system
|
CN116333057A
(zh)
|
2016-05-13 |
2023-06-27 |
4D分子治疗有限公司 |
腺相关病毒变体衣壳和其使用方法
|
LT3472317T
(lt)
|
2016-06-16 |
2022-06-27 |
Adverum Biotechnologies, Inc. |
Kompozicijos ir būdai, skirti neovaskuliarizacijos akyse sumažinimui
|
RS61311B1
(sr)
|
2016-06-16 |
2021-02-26 |
Adverum Biotechnologies Inc |
Lečenje amd korišćenjem varijante aav2 sa afliberceptom
|
US11192925B2
(en)
|
2016-10-19 |
2021-12-07 |
Adverum Biotechnologies, Inc. |
Modified AAV capsids and uses thereof
|
EP3589277A4
(de)
|
2017-02-28 |
2020-08-26 |
Adverum Biotechnologies, Inc. |
Modifizierte aav-kapside und verwendungen davon
|
AU2018234918B2
(en)
|
2017-03-17 |
2023-11-02 |
Adverum Biotechnologies, Inc. |
Compositions and methods for enhanced gene expression
|